Elicio Therapeutics Inc. (ELTX)
NASDAQ · Healthcare
Elicio Therapeutics Inc. Shareholder Equity 2020–2022
Elicio Therapeutics Inc. annual shareholder equity history from 2020 to 2022. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Elicio Therapeutics Inc. shareholder equity as of December 31, 2022: -102.1M, a 37.04% increase year-over-year.
- Elicio Therapeutics Inc. shareholder equity for 2022 were -102.1M, a 37.04% increase from 2021.
- Elicio Therapeutics Inc. shareholder equity for 2021 were -74.5M, a 17.59% decrease from 2020.
- Elicio Therapeutics Inc. shareholder equity for 2020 were -90.4M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Elicio Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2022 | $-102 |
| 2021 | $-75 |
| 2020 | $-90 |
Elicio Therapeutics Inc. Shareholder Equity — FAQ
Elicio Therapeutics Inc. (ELTX) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ELTX's shareholder equity history?
The chart and table above show Elicio Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.